logo
Share SHARE
FONT-SIZE Plus   Neg

Earnings Watch For March 29 (BBY, RIMM, TIBX)

Consumer electronics retailer Best Buy Co. Inc. (BBY) is scheduled to report fourth-quarter results. The company is expected to post earnings of $2.16 per share, higher than the year-ago quarter's $1.98 per share. Also, the company is anticipated to generate revenues of $17.21 billion, up from $16.26 billion in the prior-year quarter. The company's shares closed Wednesday's session at $26.62. (The stock up about 1% in Q4; MA(50)- $25.28; MA(100)- $25.45; 52-wk H/L $32.85/$21.79)

Research In Motion Ltd. (RIMM) is slated to report results for the fourth quarter. The smartphone maker is expected to earn $0.81 per share compared to $1.78 per share last year, on revenues of $4.54 billion. The stock closed Wednesday at $13.67. (The stock plunged around 29% in Q4; MA(50)- $14.94; MA(100)- $15.65; 52-wk H/L $57.32/$12.45)

TIBCO Software Inc. (TIBX) is expected to post first-quarter results. The company is expected to report earnings of $0.19 per share on revenues of $222.36 million. Last year, earnings and revenue were $0.16 per share and $185.34 million respectively. The company's shares closed Wednesday's regular trading at $31.01. (The stock rose around 7% in Q1; MA(50)- $28.44; MA(100)- $27.21; 52-wk H/L $32.20/$18.43)

Cache Inc. (CACH), Shaw Group Inc. (SHAW), Worthington Industries, Inc. (WOR) and Xyratex Ltd. (XRTX) are also due to report their results today.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT